# US 2024/0189476 A1 · Photo-crosslinkable plant-based materials, methods of manufacture thereof and articles comprising the same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0189476 A1
- Document ID: US20240189476A1
- Status: Published application
- Kind: A1
- Application number: 18/535,288
- Filed: 2023-12-11
- Published: 2024-06-13
- Earliest claimed: 2022-12-09
- Applicants: University of Connecticut
- Inventors: Ali Tamayol; Mohamadmahdi Samandari; Farnoosh Saeedinejad; Jacob P. Quint; Elmira Arab Tehrany-Kahn; Cyril Kahn
- Web page: https://patentgrep.com/patent/US20240189476A1

## CPC

- A61L 27/227: {Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24}
- A61L 27/56: Porous materials, {e.g. foams or sponges}
- A61L 27/58: Materials at least partially resorbable by the body
- B33Y 10/00: Processes of additive manufacturing
- B33Y 70/00: Materials specially adapted for additive manufacturing
- B33Y 70/10: Composites of different types of material, e.g. mixtures of ceramics and polymers or mixtures of metals and biomaterials
- B33Y 80/00: Products made by additive manufacturing
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- B33Y: ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING

## Abstract

A biomaterial composition includes an uncrosslinked plant-based biomaterial functionalized with reactive groups that are operative to undergo a crosslinking reaction via free radical polymerization. A method for producing a biomaterial composition includes functionalizing an uncrosslinked plant-based biomaterial with reactive groups that are operative to undergo a crosslinking reaction via free radical polymerization to form a functionalized uncrosslinked plant-based biomaterial. Additional embodiments are provided.

## Claims

### Claim 1

A biomaterial composition comprising:
an uncrosslinked plant-based biomaterial functionalized with reactive groups that are operative to undergo a crosslinking reaction via free radical polymerization.

### Claim 2 (depends on 1)

The biomaterial composition of claim 1, further comprising a photoinitiator package that is activated via exposure to electromagnetic radiation.

### Claim 3 (depends on 1)

The biomaterial composition of claim 1, further comprising an initiator package that comprises thermal, redox, ionizing, electrochemical, plasma, sonication, ternary initiators, or a combination thereof that are operative to induce crosslinking via a free radical reaction upon being activated by stimuli that do not include electromagnetic radiation.

### Claim 4 (depends on 1)

The biomaterial composition of claim 1, where the free radical polymerization induces crosslinking of the uncrosslinked plant-based biomaterial to form a crosslinked biomaterial.

### Claim 5 (depends on 4)

The biomaterial composition of claim 4, where the crosslinked biomaterial is a construct that is seeded with cells after the crosslinking.

### Claim 6 (depends on 1)

The biomaterial composition of claim 1, where the uncrosslinked plant-based biomaterial functionalized with reactive groups comprises at least 40% by weight of plant-based protein.

### Claim 7 (depends on 1)

The biomaterial composition of claim 1, where the biomaterial composition is further mixed with cells to form a bioink prior to undergoing free radical polymerization.

### Claim 8 (depends on 7)

The biomaterial composition of claim 7, where the bioink is used to biofabricate a construct; where the construct is cured either simultaneously or sequentially with the biofabrication.

### Claim 9 (depends on 1)

The biomaterial composition of claim 1, where the biomaterial composition is in the form of a liquid foam prior to the free radical polymerization.

### Claim 10 (depends on 1)

The biomaterial composition of claim 1, where the biomaterial composition is in the form of an unfoamed liquid prior to the free radical polymerization.

### Claim 11 (depends on 9)

The biomaterial composition of claim 9, where the liquid foam is mixed with cells to form a bioink.

### Claim 12 (depends on 1)

The biomaterial composition of claim 1, further comprising at least one additive, where at least one additive comprises nanoparticles, microparticles, nanofibers, microfibers, antimicrobial compounds, antibiotics, bioceramics, ceramics, oxygen-generating materials, at least one vitamin, at least one protein, at least one lipid, at least one phospholipid, at least one fatty acid, biological factors, polysaccharides, nucleic acids, growth factors, hydroxyapatite, calcium, phosphate, dopamine-based material, carbon nanotubes, graphene, graphene oxide, carbon derived materials, liquid crystals, peptides, chitosan, alginate, silver-based materials, platelet-rich plasma, blood-derived materials, food additives, heme protein, hemoglobin, myoglobin, taste and smell molecules, dyes, other plant-derived materials, antioxidants, antiozonants, thermal stabilizers, mold release agents, or a combination thereof.

### Claim 13 (depends on 12)

The biomaterial composition of claim 12, wherein the additive is provided in a concentration from 0 to about 90% weight percent, based on a total weight of the construct.

### Claim 14 (depends on 6)

The biomaterial composition of claim 6, where the plant-based protein comprises plant albumin, globulin, glutelin, legumin, vicilin, gliadin, glutenin, zein, cupin and/or transferrin.

### Claim 15 (depends on 6)

The biomaterial composition of claim 6, where the plant-based protein is derived from legumes, nuts, grains, seeds, leaves, stems, roots, flowers, fruits, or a combination thereof.

### Claim 16

A method for producing a biomaterial composition, the method comprising:
functionalizing an uncrosslinked plant-based biomaterial with reactive groups that are operative to undergo a crosslinking reaction via free radical polymerization to form a functionalized uncrosslinked plant-based biomaterial.

### Claim 17 (depends on 16)

The method of claim 16, further comprising crosslinking the functionalized uncrosslinked plant-based biomaterial to form a construct; where the crosslinking occurs either prior to or after the inclusion of encapsulated cells, particles, drugs, food additives, dyes, proteins, lipids, polymers, or a combination thereof into a functionalized plant-based biomaterial.

### Claim 18 (depends on 16)

The method of claim 16, further comprising foaming the functionalized, uncrosslinked plant-based biomaterial and blending it with cells to form a bioink.

### Claim 19 (depends on 18)

The method of claim 18, further comprising crosslinking the bioink either sequentially or simultaneously during biofabrication.

### Claim 20 (depends on 19)

The method of claim 19, where the biofabrication includes extrusion, 3D bioprinting, stereolithography, molding, surface patterning, spinning, electrospinning, wet spinning, self assembly, emulsification, or a combination thereof.
